4//SEC Filing
Glickman Mark A 4
Accession 0001209191-22-021793
CIK 0000025743other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:15 PM ET
Size
6.1 KB
Accession
0001209191-22-021793
Insider Transaction Report
Form 4
Glickman Mark A
Chief Business Officer
Transactions
- Award
Performance Stock Units
2022-03-31+260,000→ 260,000 totalExercise: $0.00→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]The performance stock units ("PSUs") vest on April 5, 2025 based the total shareholder return ("TSR") of the issuer over the period from April 1, 2022 to March 31, 2025 and are subject to the continuous service of the reporting person with the issuer. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs, depending on the TSR milestone achieved. Each PSU represents a contingent right to receive one share of common stock of the issuer.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001441461
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 5:15 PM ET
- Size
- 6.1 KB